Pentixapharm Holding AG (PTP)

BRIEF

published on 11/21/2024 at 11:05, 1 month ago

Pentixapharm Advancing Clinical Trials for Leukemia Treatment

Clinical Trial Radiopharmaceuticals Pentixapharm Lu-177 Leukemia Treatment
PRESS RELEASE

published on 11/21/2024 at 11:00, 1 month ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies

Phase I/II Trial Leukemia Pentixapharm Radiotherapy Lu177-PentixaTher
BRIEF

published on 11/12/2024 at 17:50, 1 month 8 days ago

Pentixapharm Reports Third Quarter 2024 Interim Results

Interim Report Spin-off Financial Loss Third Quarter Pentixapharm
PRESS RELEASE

published on 11/12/2024 at 17:45, 1 month 8 days ago

Pentixapharm Releases Interim Report for the Third Quarter of 2024
Pentixapharm Holding AG releases interim report for third quarter of 2024, reporting a loss of €49k with no revenue. Anticipates significant increase in losses for 2024 consolidated annual financial statements

Financial Statements Revenue Interim Report Loss Pentixapharm
BRIEF

published on 11/04/2024 at 17:31, 1 month 17 days ago

Pentixapharm Applauds CMS Reimbursement Enhancement for Radiopharmaceuticals

Radiopharmaceuticals Pentixapharm CMS Decision Reimbursement Policy Diagnostic Innovation
PRESS RELEASE

published on 11/04/2024 at 17:26, 1 month 17 days ago

Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals
Pentixapharm welcomes CMS decision to enhance reimbursement for diagnostic radiopharmaceuticals, which could impact future streams for Ga68-PentixaFor and have broader market implications

Radiopharmaceuticals Reimbursement Pentixapharm Ga68-PentixaFor CMS Decision
BRIEF

published on 10/29/2024 at 11:51, 1 month 23 days ago

Pentixapharm's PentixaFor Enters Advanced US Clinical Trials

Clinical Trial Pentixapharm PentixaFor Adrenal Tumors PET Scans
PRESS RELEASE

published on 10/29/2024 at 11:46, 1 month 23 days ago

Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome

Clinical Trial PentixaFor Adrenal Tumors PET Scans NIH
BRIEF

published on 10/28/2024 at 12:31, 1 month 24 days ago

Nuclear Medicine Expert Ken Herrmann Joins Pentixapharm's Board

Supervisory Board Nuclear Medicine Radiopharmaceuticals Oncology Pipeline Ken Herrmann
PRESS RELEASE

published on 10/28/2024 at 12:26, 1 month 24 days ago

Nuclear Medicine Specialist Ken Herrmann Joins Supervisory Board of Pentixapharm Holding AG
Nuclear Medicine Specialist Ken Herrmann joins Pentixapharm Holding AG's Supervisory Board, bringing expertise in radiopharmaceuticals and theranostics. His appointment aims to advance oncology pipeline

Oncology Nuclear Medicine Radiopharmaceuticals Pentixapharm Ken Herrmann

Published on 12/21/2024 at 01:30, 16 hours 6 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 16 hours 6 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 17 hours 31 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 17 hours 36 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 18 hours 6 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 16 hours 44 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 16 hours 50 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 22 hours 25 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 22 hours 39 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 23 hours 35 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 5 hours 18 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 23 hours 36 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 23 hours 41 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 3 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 23 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News